Certara to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Certara (Nasdaq: CERT), a global leader in model-informed drug development, has announced its participation in two upcoming investor conferences in September 2025.
Management will present at the Baird Global Healthcare Conference on Tuesday, September 9 at 10:15 a.m. ET, followed by the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10 at 12:20 p.m. ET. Both presentations will be available via webcast on Certara's investor relations website with replay access for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, CERT declined 1.50%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- Baird Global Healthcare Conference
Date and Time: Tuesday, September 9 at 10:15 a.m. ET
- Morgan Stanley 23rd Annual Global Healthcare Conference
Date and Time: Wednesday, September 10 at 12:20 p.m. ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com